NYC-WTC_000195120

NYC 9/11 Public Portal Document

ASBESTOS HAZARDTEXT ® - Hazard Management Page 11 of 18

railroads: 130 Italian cases. Med Lav 1995; 86:461-477. 240. Mandel JS, Mclaughlin JK, Schlehofer B et al: International renal-cell cancer study. 4. Occupation. Intemat J Cancer 1995; 61:601-605. 241. Manos CG, Patelmandlik KJ & Lisk DJ: Prevalence of asbestos in composted waste from 26 communities in the United States. Arch Environ Contamin Toxicol 1992; 23:266-269. 242. MAPA Pioneer: Pioneers in Hand Protection World-Class Industrial Gloves Product Literature, 512 East Tiffin Street, Willard, OH 44890 (800-537-2897). 243. Mar-Mac Manufacturing, Inc.: Product Literature, P.O. Box 278, McBee, SC 29101 (800-845- 6962). 244. Marczynski B, Czuppon AB, Marek W et al: Increased incidence of DNA double-strand breaks and anti-DS DNA antibodies in blood of workers occupationally exposed to asbestos. Human Exp Toxicol 1994; 13:3-9. 245. Marigold Industrial: Industry In Safe Hands Product Literature, 3585 Engineering Drive, P.O. Box 926090, Norcross, GA 30092 (888-566-3468). 246. Markowitz SB, Morabia A, Lilis R et al: Clinical predictors of mortality from asbestosis in the North American insulator cohort, 1981 to 1991. Am J Respir Crit Care Med 1997; 156:101- 198. 247. McCann M: EPA orders schools to identify asbestos-containing material. Art Hazard News 1982; 5:2. 248. McDonald JC, Armstrong B, Case B et al: Mesothelioma and asbestos fiber type. Evidence from lung tissue analyses. Cancer 1989; 63:1544-1547. 249. McDonald JC, Sebastien P, Case B et al: Ferruginous body counts in sputum as an index of past exposure to mineral fibres. Am Occup Hyg 1992; 36:271-282. 250. McLarty JW, Greenberg SD, Hurst GA et al: The clinical significance of ferruginous bodies in sputa. J Occup Med 1980; 22:92-96. 251. McLoud TC, Woods BO, Carrington CB et al: Diffuse pleural thickening in an asbestos- exposed population: prevalence and causes. Am J Roentgenol 1985; 144:9-18. 252. McLure M & Poole C: Asbestos and kidney cancer: the evidence supports a causal association. Am J Ind Med 1990; 17:647-648. 253. Memphis Glove Company: Permeation Guide, P.O. Box 171814, Memphis, TN 38187 (800- 955-6887). 254. Metintas M, Ozdemir N, Hillerdal G et al: Environmental asbestos exposure and malignant pleural mesothelioma. Resp Med 1999; 93:349-355. 255. Miller A & Miller JA: Diffuse thickening superimposed on circumscribed pleural thickening related to asbestos exposure. Am J Ind Med 1993; 23:859-871. 256. Miller A, Teirstein AS & Selikoff U: Ventilatory failure due to asbestos pleurisy. Am J Med 1983;75:911-919. 257. Miller A: Chronic pleuritic pain in four patients with asbestos-induced pleural fibrosis. Br J Ind Med 1990; 47:147-153. 258. Mollo F, Piolatto G, Bellis D et al: Asbestos exposure and histologic cell types of lung cancer in surgical and autopsy series. Intemat J Cancer 1990; 46:576-580. 259. Montgomery Safety Products: Montgomery Safety Products Chemical Resistant Glove Guide, 1117 Marion Avenue, SW, Canton, OH 44707 (800-562-0600). 260. Mossman BT & Gee JBL: Asbestos-related diseases. N Engl J Med 1989; 320:1721-1730. 261. Mossman BT, Bignon J, Com M et al: Asbestos: scientific developments and implications for public policy. Science 1990; 247:294-301. 262. Mowe G, Gylseth B, Hartveit F et al: Occupational asbestos exposure, lung-fiber concentration and latency time in malignant mesothelioma. Scand J Work Environ Health 1984; 10:293-298. 263. Murphy RLH, Ferris BG Jr, Burgess WA et al: Effects of low concentrations of asbestos. N Engl J Med 1971; 23:1271-1278.

http://www.tomescps.com/DATA/DT/DT356-e.htm 1/4/2002

CITY_21MC100_012170721

NYC-WTC_000195155